DIN 02322323 · ended Jun 5, 2023 · Requirements related to complying with good manufacturing practices.
Resolved
TEVA-NARATRIPTAN
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 02314304 · ended Feb 14, 2023 · Disruption of the manufacture of the drug.
Discontinued
AMERGE
2.5MG · TABLET · GLAXOSMITHKLINE INC
DIN 02237821
Showing 12 of 28 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Naratriptan. Health Canada has 28 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Naratriptan is classified under “ANTIMIGRAINE PREPARATIONS” (ATC N02CC).
Recent changes
No changes recorded yet.
Common questions
What is Naratriptan used for?
A triptan used to treat migraine headaches.
When will Naratriptan be back in stock in Canada?
Naratriptan has no active shortage; supply is normal per Health Canada reports.
Why is Naratriptan in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.